Pyrazinamide: Clinical Trials

10 trials of Pyrazinamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown, 4 completed. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Unknown 6, Completed 4

Follow Pyrazinamide: new trials by email Literature Review of Pyrazinamide trials Research Report on Pyrazinamide

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China
Bedaquiline, Levofloxacin, Linezolid - Tuberculosis, Multidrug-Resistant
Phase 4UnknownBeijing Chest Hospital2122022-05-102023-01-18
Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
Isoniazid, Rifampicin, Pyrazinamide - Tuberculosis, Pulmonary
Phase 4UnknownBeijing Chest Hospital39002016-08-012017-03-20
The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis
Isoniazid, Rifampicin, Ethambutol - Tuberculosis, Spinal
Phase 4UnknownBeijing Chest Hospital4002015-04-012015-06-23
Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3
Xpert MTB/RIF®, Determine TB LAM, Chest X-ray, ART (Atripla, Truvada, Efavirenz, Combivir), Rifampin, isoniazid, pyrazinamide, ethambutol - HIV-1 Infection
Phase 4CompletedANRS, Emerging Infectious Diseases10502014-09-012020-10-19
Research on New Regimens for Retreatment Pulmonary Tuberculosis
Isoniazid Aminosalicylate Tablets, Streptomycin injectable - Reinfection Pulmonary Tuberculosis
Phase 4UnknownShanghai Pulmonary Hospital, Shanghai, China8642013-06-012015-01-06
Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes
Rifampicin, Isoniazid, Ethambutol, Pyrazinamide - AIDS With Tuberculosis
Phase 4UnknownMakerere University4002013-02-012015-04-13
Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment
isoniazid, rifampin, pyrazinamide - Hepatitis, Tuberculosis, Pulmonary
Phase 4UnknownNational Taiwan University Hospital1002011-07-012012-12-27
Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage
Rifampicin(max dose 10 mg/kg/day), Isoniazide (max dose 5 mg/kg/day) and Pyrazinamide (max dose 25 mg/kg/day) - Drug Induced Hepatotoxicity, Tuberculosis
Phase 4CompletedAll India Institute of Medical Sciences1752006-12-012012-02-16
A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy
isoniazid, rifampin + isoniazid, rifampin + pyrazinamide or not treatment - HIV Infections, Tuberculosis
Phase 4CompletedSociedad Andaluza de Enfermedades Infecciosas3321994-01-012008-10-24
Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis
isoniazid, rifampin + isoniazid or rifampin + pyrazinamide - HIV Infections
Phase 4CompletedSociedad Andaluza de Enfermedades Infecciosas3001994-01-012007-01-11

Conditions studied

Tuberculosis (6)  ·  Acquired Immunodeficiency Syndrome (2)  ·  HIV Infections (2)  ·  Tuberculosis, Pulmonary (2)  ·  Chemical and Drug Induced Liver Injury (1)  ·  Hepatitis (1)  ·  Tuberculosis, Multidrug-Resistant (1)  ·  Tuberculosis, Spinal (1)

Sponsors

Beijing Chest Hospital (3)  ·  Sociedad Andaluza de Enfermedades Infecciosas (2)  ·  ANRS, Emerging Infectious Diseases (1)  ·  All India Institute of Medical Sciences (1)  ·  Makerere University (1)  ·  National Taiwan University Hospital (1)  ·  Shanghai Pulmonary Hospital, Shanghai, China (1)

Countries

China (4)  ·  Spain (2)  ·  Uganda (2)  ·  Cambodia (1)  ·  Côte d’Ivoire (1)  ·  India (1)  ·  Taiwan (1)  ·  Vietnam (1)

Top investigators

Antonio Rivero, MD PhD (2)  ·  Felipes Diez, MD (2)  ·  Fernando Lozano, MD PhD (2)  ·  Jose Carlos Escribano, MD (2)  ·  Juan Jose Hernandez, MD (2)  ·  Juan Pasquau, MD (2)  ·  Manuel Marquez, MD (2)  ·  Rafael Castillo, MD (2)  ·  Barbara Castelnuovo, MD, PhD (1)  ·  Heping Xiao, M.D (1)

Results publications

PMID 12809582, PMID 20156055, PMID 28399802, PMID 28629333, PMID 28928173, PMID 29162063, PMID 29514175, PMID 29519716, PMID 30910890, PMID 32558469, PMID 36883573, PMID 38561815, PMID 41925982